You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • THU0579 Treating To Target with Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis: Results from The Long-Term Extension The Phase III Pivotal Trial

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Other orphan diseases
THU0579 Treating To Target with Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis: Results from The Long-Term Extension The Phase III Pivotal Trial

 

Online download statistics by month:

Online download statistics by month: July 2016 to March 2024

AbstractFullPdf
Jul 2016500
Aug 20161602
Sep 2016702
Oct 20161601
Nov 20162702
Dec 20161400
Jan 20172000
Feb 20171300
Mar 20172303
Apr 20171202
May 20171603
Jun 2017700
Jul 20171200
Aug 20171400
Sep 20172801
Oct 20172002
Nov 20172402
Dec 20171401
Jan 20181801
Feb 20181200
Mar 20181804
Apr 20181800
May 20182000
Jun 20181603
Jul 20182000
Aug 2018801
Sep 2018800
Oct 20181600
Nov 2018400
Dec 2018800
Jan 2019300
Mar 2019600
Apr 2019600
May 2019300
Jun 2019800
Jul 2019300
Aug 2019100
Sep 2019200
Oct 2019401
Nov 2019801
Dec 2019300
Jan 2020200
Feb 2020200
May 2020200
Jun 2020400
Jul 2020600
Sep 20202000
Oct 2020300
Nov 2020400
Dec 2020300
Jan 2021400
Feb 2021100
Apr 2021300
May 2021200
Sep 2021200
Oct 2021200
Nov 2021500
Dec 2021800
Jan 2022500
Feb 2022700
Mar 2022600
May 20221100
Jun 20221201
Jul 20224200
Aug 20223401
Sep 20222401
Oct 2022200
Nov 2022400
Dec 20221402
Jan 2023900
Feb 2023800
Mar 2023400
Apr 2023400
May 2023400
Jun 2023201
Jul 2023400
Aug 2023100
Sep 20231600
Oct 2023500
Dec 2023500
Jan 2024400
Feb 2024800
Mar 2024200
Total811038